clonidine has been researched along with Chronic Kidney Failure in 43 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clonidine has clearly been shown to be effective in the treatment of all grades of hypertension." | 10.14 | Clonidine in the treatment of hypertension. ( Garrett, BN; Kaplan, NM, 1980) |
| " During the 33 days before admission, she received oral tizanidine hydrochloride at 3 mg/day for leg cramps." | 7.73 | Symptomatic bradycardia probably due to tizanidine hydrochloride in a chronic hemodialysis patient. ( Abe, T; Akizawa, T; Kamimura, M; Kitabata, Y; Kobata, H; Narukawa, N; Orita, H; Shiizaki, K, 2005) |
| "Restless legs syndrome is a common and sometimes incapacitating disorder in chronic uraemic patients." | 6.66 | [Successful clonidine treatment of restless leg syndrome in chronic kidney insufficiency]. ( Ausserwinkler, M; Schmidt, P, 1989) |
| "Clonidine has clearly been shown to be effective in the treatment of all grades of hypertension." | 6.14 | Clonidine in the treatment of hypertension. ( Garrett, BN; Kaplan, NM, 1980) |
| " It has also been used intravenously in phaeochromocytoma, tetanus, clonidine withdrawal, and as an adjunct to halothane to produce hypotensive anaesthesia." | 4.76 | Combined alpha- and beta-receptor inhibition in the treatment of hypertension. ( Prichard, BN, 1984) |
| " During the 33 days before admission, she received oral tizanidine hydrochloride at 3 mg/day for leg cramps." | 3.73 | Symptomatic bradycardia probably due to tizanidine hydrochloride in a chronic hemodialysis patient. ( Abe, T; Akizawa, T; Kamimura, M; Kitabata, Y; Kobata, H; Narukawa, N; Orita, H; Shiizaki, K, 2005) |
| " Muzolimine benefited hypertension in patients with expansion of the extracellular space and it also strengthened the effect of clonidine or minoxidil." | 3.67 | Muzolimine in advanced chronic renal failure. ( Alfonso, L; Aprile, M; Corlianò, C; De Blasi, V; Mastrangelo, F; Montinaro, AM; Napoli, M; Rizzelli, S, 1985) |
| "The effect of clonidine on the relationship between sympathetic nervous system activity and the state of sodium-volume balance was studied in 15 patients with essential hypertension and normal renal function (group 1) and in 14 patients with hypertension and mild to moderate renal failure (group 2)." | 3.66 | Effects of acute and chronic treatment with clonidine. ( Campese, VM; Massry, SG, 1983) |
| "Twenty-eight adult chronic renal failure patients (ASA physical status III) scheduled for arteriovenous fistula construction were studied in a prospective, randomized, double-blind, controlled design." | 2.71 | Clonidine as an adjuvant for lidocaine in axillary brachial plexus block in patients with chronic renal failure. ( Adnan, T; Ayşe, K; Elif, AA; Gülnaz, A, 2005) |
| "Restless legs syndrome is a common and sometimes incapacitating disorder in chronic uraemic patients." | 2.66 | [Successful clonidine treatment of restless leg syndrome in chronic kidney insufficiency]. ( Ausserwinkler, M; Schmidt, P, 1989) |
| "We report a case where gustatory sweating repeatedly developed on peritoneal dialysis that resolved on periods of hemodialysis." | 1.35 | Gustatory sweating recurring on peritoneal dialysis but resolving during periods of hemodialysis. ( Carter, TB; Dansby, LM; Diskin, CJ; Radcliff, L; Stokes, TJ, 2008) |
| " Weekly dosing of continuously released antihypertensive agents may result in better blood pressure control than conventional daily dosing." | 1.29 | Use of transdermal clonidine in chronic hemodialysis patients. ( Johnson, KL; McConnell, J; Rosansky, SJ, 1993) |
| " When transdermal clonidine was substituted for twice daily dosage of oral clonidine, blood pressure decreases were fully maintained." | 1.29 | The use of transdermal clonidine in the hypertensive patient with chronic renal failure. ( Cristal, N; Lowenthal, DT; Paran, E; Saris, SD, 1993) |
| " Its frequency is influenced by length of treatment, daily dosage and degree of hypertension." | 1.27 | [Hypertensive crisis after withdrawal of clonidine and nadolol. Case report and review of the literature]. ( Fried, M; Schwander, J, 1987) |
| " The age, degree of renal impairment, plasma renin activity, and number and dosage of antihypertensive medicines did not account for these differences in NE." | 1.26 | Effect of antihypertensive therapy on plasma catecholamines in renal failure patients. ( Anderson, S; Cronin, R; Henrich, WL; Mitchell, H; Pettinger, WA, 1981) |
| "Renal disease and hypertension is a continuing challenge to the nephrologist." | 1.26 | The kidney and antihypertensive therapy. ( Bailey, RR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (58.14) | 18.7374 |
| 1990's | 11 (25.58) | 18.2507 |
| 2000's | 7 (16.28) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schlaich, MP | 1 |
| Socratous, F | 1 |
| Hennebry, S | 1 |
| Eikelis, N | 1 |
| Lambert, EA | 1 |
| Straznicky, N | 1 |
| Esler, MD | 1 |
| Lambert, GW | 1 |
| Morimoto, S | 1 |
| Aota, Y | 1 |
| Sakuma, T | 1 |
| Ichibangase, A | 1 |
| Ikeda, K | 1 |
| Sawada, S | 1 |
| Iwasaka, T | 1 |
| Wallace, EL | 1 |
| Lingle, K | 1 |
| Pierce, D | 1 |
| Satko, S | 1 |
| Ye, S | 1 |
| Zhong, H | 1 |
| Yanamadala, V | 1 |
| Campese, VM | 3 |
| Adnan, T | 1 |
| Elif, AA | 1 |
| Ayşe, K | 1 |
| Gülnaz, A | 1 |
| Kitabata, Y | 1 |
| Orita, H | 1 |
| Kamimura, M | 1 |
| Shiizaki, K | 1 |
| Narukawa, N | 1 |
| Abe, T | 1 |
| Kobata, H | 1 |
| Akizawa, T | 1 |
| Diskin, CJ | 1 |
| Stokes, TJ | 1 |
| Dansby, LM | 1 |
| Radcliff, L | 1 |
| Carter, TB | 1 |
| Prichard, BN | 1 |
| Garrett, BN | 1 |
| Kaplan, NM | 1 |
| Campanacci, L | 1 |
| Bellini, G | 1 |
| Battilana, G | 1 |
| Rigoni, A | 1 |
| Cosenzi, A | 1 |
| Carretta, R | 1 |
| Puppis, E | 1 |
| Pierini, B | 1 |
| Faccini, L | 1 |
| Massry, SG | 1 |
| Lowenthal, DT | 2 |
| Affrime, MB | 1 |
| Meyer, A | 1 |
| Kim, KE | 1 |
| Falkner, B | 1 |
| Sharif, K | 1 |
| Henrich, WL | 1 |
| Mitchell, H | 1 |
| Anderson, S | 1 |
| Cronin, R | 1 |
| Pettinger, WA | 1 |
| Deucher, F | 1 |
| Nöthiger, F | 2 |
| Soliman, AT | 1 |
| Mohsin, N | 1 |
| al Hasani, M | 1 |
| Elbualy, M | 1 |
| O'Connor, DT | 1 |
| Cervenka, JH | 1 |
| Stone, RA | 1 |
| Parmer, RJ | 1 |
| Franco-Bourland, RE | 1 |
| Madrazo, I | 1 |
| Langlais, PJ | 1 |
| Sacchetti, A | 1 |
| McCabe, J | 1 |
| Torres, M | 1 |
| Harris, RL | 1 |
| Rosansky, SJ | 1 |
| Johnson, KL | 1 |
| McConnell, J | 1 |
| Saris, SD | 1 |
| Paran, E | 1 |
| Cristal, N | 1 |
| Gilbert, RD | 1 |
| Kahn, D | 1 |
| Cassidy, M | 1 |
| Díez, J | 1 |
| Iglesias, P | 2 |
| Sastre, J | 2 |
| Méndez, J | 2 |
| Selgas, R | 2 |
| Gómez-Pan, A | 2 |
| Bertuccio, C | 1 |
| Ibarra, FR | 1 |
| Pignataro, O | 1 |
| Toledo, J | 1 |
| Paz, L | 1 |
| Arrizurieta, E | 1 |
| Martin, RS | 1 |
| Bailey, RR | 1 |
| Hulter, HN | 1 |
| Licht, JH | 1 |
| Ilnicki, LP | 1 |
| Singh, S | 1 |
| Ban, M | 1 |
| Matsuno, T | 1 |
| Ogawa, K | 1 |
| Satake, T | 1 |
| de Fremont, JF | 1 |
| Coevoet, B | 1 |
| Andrejak, M | 1 |
| Makdassi, R | 1 |
| Quichaud, J | 1 |
| Lambrey, G | 1 |
| Gueris, J | 1 |
| Caillens, C | 1 |
| Harichaux, P | 1 |
| Alexandre, JM | 1 |
| Fournier, A | 1 |
| Oesch, I | 1 |
| Blumberg, A | 1 |
| Curtis, JR | 1 |
| Bateman, FJ | 1 |
| White, RP | 1 |
| Díez, JJ | 1 |
| Romero, JR | 1 |
| Favazza, A | 1 |
| Motanaro, D | 1 |
| Messa, P | 1 |
| Antonucci, F | 1 |
| Gropuzzo, M | 1 |
| Mioni, G | 1 |
| Vanholder, R | 1 |
| Lamiere, N | 1 |
| Ringoir, S | 1 |
| Ausserwinkler, M | 1 |
| Schmidt, P | 1 |
| Fried, M | 1 |
| Schwander, J | 1 |
| Ho, KY | 1 |
| Evans, WS | 1 |
| Thorner, MO | 1 |
| Mastrangelo, F | 1 |
| Rizzelli, S | 1 |
| Corlianò, C | 1 |
| Alfonso, L | 1 |
| De Blasi, V | 1 |
| Aprile, M | 1 |
| Montinaro, AM | 1 |
| Napoli, M | 1 |
| Fritel, D | 1 |
| Baglin, A | 1 |
| Rahn, KH | 1 |
| De Conca, V | 1 |
| Michetti, P | 1 |
| Safar, M | 1 |
| Milliez, P | 1 |
| Rorive, G | 1 |
| Teodoresco, P | 1 |
| Câmpeanu, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Renal SympAthetic DenerVation on Chronic HypErtension[NCT01628198] | 38 participants (Actual) | Interventional | 2011-10-31 | Terminated (stopped due to recommendation by the study's DSMB due to insufficient data to determine efficacy.) | |||
| Renal Sympathetic Denervation for the Management of Chronic Hypertension[NCT01628172] | 96 participants (Actual) | Interventional | 2011-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The change in diastolic blood pressure as measured by 24 hour ambulatory monitoring at 6 months as compared to from baseline. (NCT01628198)
Timeframe: baseline and 6 months
| Intervention | mmHg mean change (Mean) |
|---|---|
| Renal Denervation Group | -5.5 |
The change in systolic blood pressure as measured by 24 hour ambulatory monitoring at 6 months as compared to from baseline. (NCT01628198)
Timeframe: baseline and 6 months
| Intervention | mmHg (Mean) |
|---|---|
| Renal Denervation Group | -10.2 |
The total number of anti-hypertensive medications at baseline, 6 months, and 12 months (NCT01628198)
Timeframe: Baseline, 6 months, 12 months
| Intervention | medications (Mean) | ||
|---|---|---|---|
| Baseline | 6 months | 12 months | |
| Renal Denervation Group | 5.37 | 4.79 | 4.64 |
A blood urea nitrogen (BUN) test measures the amount of nitrogen in blood that comes from the waste product urea. Urea is made when protein is broken down in the body. Urea is made in the liver and passed out in the urine. (NCT01628198)
Timeframe: baseline, 6 months, 12 months
| Intervention | mg/dL (Mean) | ||
|---|---|---|---|
| Baseline | 6 months | 12 months | |
| Renal Denervation Group | 20.82 | 22.15 | 23.11 |
Creatinine measures the level of the waste product in the body. The amount of creatinine in the blood depends partly on the amount of muscle tissue you have. Men generally have higher creatinine levels than women.Normal levels of creatinine in the blood are approximately 0.6 to 1.2 milligrams (mg) per deciliter (dL) in adult males and 0.5 to 1.1 milligrams per deciliter in adult females. High levels of creatinine indicates kidney impairment. (NCT01628198)
Timeframe: baseline, 6 months, 12 months
| Intervention | mg/dl (Mean) | ||
|---|---|---|---|
| Baseline | 6 months | 12 months | |
| Renal Denervation Group | 1.6 | 1.68 | 2.03 |
Different time points office diastolic blood pressure measurements (NCT01628198)
Timeframe: baseline, 6 month, 12 months
| Intervention | mm Hg (Mean) | ||
|---|---|---|---|
| Baseline | 6 months | 12 months | |
| Renal Denervation Group | 87.06 | 86.93 | 87.75 |
Different time points office systolic blood pressure measurements (NCT01628198)
Timeframe: baseline, 6 month, 12 months
| Intervention | mm Hg (Mean) | ||
|---|---|---|---|
| Baseline | 6 months | 12 months | |
| Renal Denervation Group | 156.86 | 151.19 | 158.45 |
Renal artery blood flow as measured by Renal Aortic Ratio (RAR) = Peak systolic Velocity renal artery / Peak Systolic Velocity Aorta. A >60% stenosis is reported when there is a >3.5:1 Renal to Aortic Ratio. (NCT01628198)
Timeframe: Baseline and 12 months
| Intervention | ratio (Mean) | |||
|---|---|---|---|---|
| Baseline Right RAR | Baseline Left RAR | 12 months Right RAR | 12 months Left RAR | |
| Renal Denervation Group | 1.38 | 1.52 | 1.41 | 1.52 |
Dimensions of renal artery, right and left (NCT01628198)
Timeframe: baseline and 12 months
| Intervention | mm (Mean) | |||
|---|---|---|---|---|
| Baseline R Kidney | Baseline L Kidney | 12 months R Kidney | 12 months L Kidney | |
| Renal Denervation Group | 11.43 | 11.68 | 11.26 | 11.39 |
Renal artery blood flow as measured by Resistive Index. RI = (peak systolic velocity - end diastolic velocity ) / peak systolic velocity. the normal value is ~ 0.60, with 0.70 being around the upper limits of normal (NCT01628198)
Timeframe: Baseline and 12 months
| Intervention | index (Mean) | |||
|---|---|---|---|---|
| Baseline Right RI | Baseline Left RI | 12 months Right RI | 12 months Left RI | |
| Renal Denervation Group | 0.67 | 0.72 | 0.72 | 0.72 |
5 reviews available for clonidine and Chronic Kidney Failure
| Article | Year |
|---|---|
Sympathetic activation in chronic renal failure.
Topics: Animals; Cardiovascular Diseases; Catecholamines; Clonidine; Debrisoquin; Disease Models, Animal; Ef | 2009 |
Sympathetic activation in chronic renal failure.
Topics: Animals; Cardiovascular Diseases; Catecholamines; Clonidine; Debrisoquin; Disease Models, Animal; Ef | 2009 |
Sympathetic activation in chronic renal failure.
Topics: Animals; Cardiovascular Diseases; Catecholamines; Clonidine; Debrisoquin; Disease Models, Animal; Ef | 2009 |
Sympathetic activation in chronic renal failure.
Topics: Animals; Cardiovascular Diseases; Catecholamines; Clonidine; Debrisoquin; Disease Models, Animal; Ef | 2009 |
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihyp | 1984 |
Clonidine in the treatment of hypertension.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clonidine; Diuretics; Drug Therapy, Combination; | 1980 |
Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Drug Combinations; Humans; Hyperten | 1988 |
Disorders of prolactin and growth hormone secretion.
Topics: Acromegaly; Arginine; Clonidine; Dwarfism; Female; Glucose Tolerance Test; Growth Hormone; Growth Ho | 1985 |
8 trials available for clonidine and Chronic Kidney Failure
| Article | Year |
|---|---|
Clonidine as an adjuvant for lidocaine in axillary brachial plexus block in patients with chronic renal failure.
Topics: Adjuvants, Anesthesia; Adrenergic alpha-Agonists; Aged; Anastomosis, Surgical; Anesthetics, Local; B | 2005 |
Clonidine in the treatment of hypertension.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clonidine; Diuretics; Drug Therapy, Combination; | 1980 |
Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anemia; Clonidine; Erythropoietin; Female; Growth Hormone-Re | 1996 |
Use of prazosin in management of hypertension in patients with chronic renal failure and in renal transplant recipients.
Topics: Adult; Aged; Antihypertensive Agents; Chlorothiazide; Clinical Trials as Topic; Clonidine; Drug Eval | 1975 |
Peritoneal clearances in hypertensive CAPD patients after oral administration of clonidine, enalapril, and nifedipine.
Topics: Biological Transport; Clonidine; Enalapril; Female; Humans; Hypertension; Kidney Failure, Chronic; M | 1992 |
Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Drug Combinations; Humans; Hyperten | 1988 |
[Successful clonidine treatment of restless leg syndrome in chronic kidney insufficiency].
Topics: Adult; Aged; Clonidine; Double-Blind Method; Drug Evaluation; Female; Humans; Kidney Failure, Chroni | 1989 |
[Clinico-experimental evaluation of a new anti-hypertensive agent 2 (2-6 dichlorophenylamino)-imidazoline chlorhydrate].
Topics: Aged; Cardiomyopathies; Clinical Trials as Topic; Clonidine; Diabetic Angiopathies; Drug Evaluation; | 1974 |
32 other studies available for clonidine and Chronic Kidney Failure
| Article | Year |
|---|---|
Efficacy of clonidine in a patient with refractory hypertension and chronic renal failure exhibiting neurovascular compression of the rostral ventrolateral medulla.
Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Creatinine; Drug Resistance; Humans; Hypertensio | 2009 |
Amlodipine-induced myoclonus.
Topics: Aged; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Diuretics; Humans; H | 2009 |
Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity.
Topics: Adrenergic alpha-Antagonists; Afferent Pathways; Animals; Clonidine; Denervation; Disease Models, An | 2002 |
Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity.
Topics: Adrenergic alpha-Antagonists; Afferent Pathways; Animals; Clonidine; Denervation; Disease Models, An | 2002 |
Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity.
Topics: Adrenergic alpha-Antagonists; Afferent Pathways; Animals; Clonidine; Denervation; Disease Models, An | 2002 |
Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity.
Topics: Adrenergic alpha-Antagonists; Afferent Pathways; Animals; Clonidine; Denervation; Disease Models, An | 2002 |
Symptomatic bradycardia probably due to tizanidine hydrochloride in a chronic hemodialysis patient.
Topics: Aged; Bradycardia; Clonidine; Female; Humans; Kidney Failure, Chronic; Muscle Cramp; Muscle Relaxant | 2005 |
Gustatory sweating recurring on peritoneal dialysis but resolving during periods of hemodialysis.
Topics: Adult; Clonidine; Female; Glycopyrrolate; Humans; Kidney Failure, Chronic; Muscarinic Antagonists; P | 2008 |
[Central alpha-adrenergic agonist antihypertensive drugs and renal failure].
Topics: Clonidine; Female; Hemodynamics; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male | 1984 |
Effects of acute and chronic treatment with clonidine.
Topics: Adult; Blood Pressure; Clonidine; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middl | 1983 |
Pharmacokinetics and pharmacodynamics of clonidine in varying states of renal function.
Topics: Adult; Clonidine; Female; Humans; Hypertension; Kidney Failure, Chronic; Kinetics; Male; Middle Aged | 1983 |
Effect of antihypertensive therapy on plasma catecholamines in renal failure patients.
Topics: Antihypertensive Agents; Clonidine; Humans; Hypertension; Kidney Failure, Chronic; Methyldopa; Middl | 1981 |
[Stercoraceous perforation of the colon (author's transl)].
Topics: Aluminum Hydroxide; Clonidine; Colonic Diseases; Fecal Impaction; Female; Humans; Intestinal Perfora | 1980 |
Defective clonidine-induced growth hormone secretion and normal thyroid and adrenal functions in prepubertal children with chronic renal insufficiency (CRF).
Topics: Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Anthropometry; Child; Child, Preschool; Clo | 1995 |
Neurogenic factors in hypertension: therapeutic implications.
Topics: Adult; Aged; Antihypertensive Agents; Central Nervous System; Clonidine; Hemodynamics; Humans; Hyper | 1994 |
Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity, and variation in neurologic disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amino Acid Sequence; Brain Diseases; Chromogranin A; Chrom | 1993 |
ED management of acute congestive heart failure in renal dialysis patients.
Topics: Acute Disease; Administration, Cutaneous; Administration, Oral; Administration, Sublingual; Captopri | 1993 |
Use of transdermal clonidine in chronic hemodialysis patients.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Antihypertensive Agents; Blood Pressure; Clon | 1993 |
The use of transdermal clonidine in the hypertensive patient with chronic renal failure.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Blood Pressure; Clonidine; Drug Admini | 1993 |
Interaction between clonidine and cyclosporine A.
Topics: Antihypertensive Agents; Child, Preschool; Clonidine; Cyclosporine; Drug Interactions; Humans; Immun | 1995 |
Regulation of cell cyclic AMP in medullary thick ascending limb of Henle in a rat model of chronic renal failure.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic alpha-Agonists; Animals; Calcitonin; Cell Separation; Clonid | 1998 |
The kidney and antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Clonidine; Diazoxide; Female; Humans; Hy | 1976 |
Clinical efficacy and pharmacokinetics of clonidine in hemodialysis and renal insufficiency.
Topics: Blood Pressure; Clonidine; Heart Rate; Humans; Kidney Failure, Chronic; Kinetics; Posture; Potassium | 1979 |
Plasma norepinephrine and dopamine-beta-hydroxylase activity in chronic renal failure.
Topics: Adolescent; Adult; Aged; Blood Pressure; Clonidine; Dopamine beta-Hydroxylase; Epinephrine; Heart Fa | 1979 |
Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis: comparison of metoprolol, alphamethyldopa and clonidine in a cross-over t
Topics: Clonidine; Dopamine beta-Hydroxylase; Humans; Hypertension, Renal; Kidney Failure, Chronic; Methyldo | 1979 |
[Spontaneous colon perforation in patients with chronic kidney failure].
Topics: Adult; Aluminum Hydroxide; Clonidine; Colonic Diseases; Fecal Impaction; Female; Humans; Intestinal | 1978 |
Antihypertensive agents in renal disease.
Topics: Antihypertensive Agents; Body Water; Clonidine; Diazoxide; Ethacrynic Acid; Furosemide; Guanethidine | 1977 |
Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietin.
Topics: Adolescent; Adult; Clonidine; Erythropoietin; Female; Growth Hormone; Growth Hormone-Releasing Hormo | 1992 |
[Hypertensive crisis after withdrawal of clonidine and nadolol. Case report and review of the literature].
Topics: Clonidine; Female; Humans; Hypertension; Kidney Failure, Chronic; Kidney Transplantation; Middle Age | 1987 |
Muzolimine in advanced chronic renal failure.
Topics: Acid-Base Imbalance; Acidosis; Adult; Aged; Clonidine; Diuresis; Edema; Female; Glomerular Filtratio | 1985 |
[The treatment of arterial hypertension associated with renal insufficiency].
Topics: Clonidine; Diuretics; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertension; Kidney F | 1973 |
[Differential therapeutic principles in the drug therapy of high blood pressure].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Cardiac Vol | 1974 |
[Medical treatment of severe or malignant arterial hypertension].
Topics: Antihypertensive Agents; Clonidine; Diet, Sodium-Restricted; Hemodynamics; Humans; Hypertension, Mal | 1972 |
[Hypertension of renal origin].
Topics: Clonidine; Diet, Sodium-Restricted; Glomerulonephritis; Humans; Hydralazine; Hypertension, Renal; Ki | 1973 |
[Effects of clonidine treatment in advanced forms of essential arterial hypertension].
Topics: Aged; Aortic Arch Syndromes; Bradycardia; Cerebral Hemorrhage; Chemical Phenomena; Chemistry; Chlort | 1973 |